4
Changes in Ownership
Mirum Pharmaceuticals, Inc. Filed Acc 0001209191-21-058609
Chief Scientific Officer sold 1,364 shares at $19.26 ($26,265)
- Chief Scientific Officer acquired 8,125 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Vig Pamela · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-29 | Grant or award : show line 1 in the form | +8,125 | 11,031 | D | ||
| 2021-10-01 | Sale : show line 2 in the form | −1,364 | $19.26 | $26,265 | 9,667 | D |
| Open-market sales · 1,364 sh · avg $19.26 · $26,265 | ||||||
Loading xslF345X03/doc4.xml…